Cephalalgia

Volume 25, Issue 11 p. 1101

Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial

G Boudreau, 

G Boudreau

Clinique de la Migraine Val des Arbres, Laval, Quebec, Canada

Search for more papers by this author

G Boudreau, 

G Boudreau

Clinique de la Migraine Val des Arbres, Laval, Quebec, Canada

Search for more papers by this author

First published: 18 October 2005

https://doi.org/10.1111/j.1468-2982.2005.00990_1.x

No abstract is available for this article.

References

• 1 Padberg M, Bruijn SFTM, De Haan RJ, Tavy DLJ. Treatment of chronic tension-type headache with botulinum toxin: a double blind, placebo-controlled clinical trial. Cephalalgia 2004; 24: 675–80.
  10.1111/j.1468-2982.2004.00738.x

  CAS PubMed Web of Science® Google Scholar
• 2 Ashina M. Review on the neurobiology of chronic tension-type headache. Cephalalgia 2004; 24: 161–72.
  10.1111/j.1468-2982.2003.00644.x

  CAS PubMed Web of Science® Google Scholar
• 3 Durham PI, Cady R, Cady R. The regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implication for migraine therapy. Headache 2004; 44: 35–43.
  10.1111/j.1526-4610.2004.04007.x

  PubMed Web of Science® Google Scholar
• 4 Evers S, Rahmann A, Vollmer-Haase J, Husstedt I-W. Treatment of headached with botulinum toxin A – a review according to evidence-based medecine criteria. Cephalalgia 2002; 22: 699–710.
  10.1046/j.1468-2982.2002.00390.x

  CAS PubMed Web of Science® Google Scholar
• 5 Blumenfeld A. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Headache 2003; 43: 853–60.
  10.1046/j.1526-4610.2003.03163.x

  PubMed Web of Science® Google Scholar

Volume25, Issue11

November 2005

Page 1101

• References

• Related

• Information

Close Figure Viewer

Previous FigureNext Figure

Caption

Download PDF